Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Carcinoma

Explore clinical trials studying Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

102 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Carcinoma trial results

Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions
Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Riverside Methodist Hospital Columbus, Ohio, United States
View Trial Details
Completed

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

NCT00352300

Conditions
Adnexal Diseases, Agranulocytosis, Communicable Diseases, +32 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • New York University Langone Medical Center New York, United States
View Trial Details
Completed

Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels

NCT00083928

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Desert Oasis Cancer Center Casa Grande, Arizona, United States
  • California Oncology of the Central Valley Fresno, California, United States
  • USC Keck School of Medicine Women's and Childrens Hospital Los Angeles, California, United States
View all 24 locations
View Trial Details
Completed

Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

NCT00407563

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations
  • Little Rock Hematology Oncology Little Rock, Arkansas, United States
  • Wilshire Oncology Medical Group, Inc. La Verne, California, United States
  • Northeast Georgia Cancer Care, LLC Athens, Georgia, United States
  • Southeastern Gynecologic Oncology, LLC Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

NCT02345265

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer

NCT05446298

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Cancer Treatment Centers of America, Phoenix. 403 Goodyear, Arizona, United States
  • Honor Health, USOR, 406 Phoenix, Arizona, United States
  • Nuvance Health System, 401 Danbury, Connecticut, United States
  • Baptist MD Anderson Cancer Center, 404 Jacksonville, Florida, United States
View all 21 locations
View Trial Details

Related conditions